Insights into pediatric rhabdomyosarcoma research: Challenges and goals
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insights into pediatric rhabdomyosarcoma research: Challenges and goals
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume -, Issue -, Pages e27869
Publisher
Wiley
Online
2019-06-21
DOI
10.1002/pbc.27869
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish
- (2019) Chuan Yan et al. CELL
- Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group
- (2018) Lisa A. Teot et al. CANCER
- Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors
- (2018) Catherine J. Drummond et al. CANCER CELL
- Vangl2/RhoA Signaling Pathway Regulates Stem Cell Self-Renewal Programs and Growth in Rhabdomyosarcoma
- (2018) Madeline N. Hayes et al. Cell Stem Cell
- The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis
- (2018) Michael D. Deel et al. CLINICAL CANCER RESEARCH
- Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for disseminated intra-abdominal malignancies in children—a single-institution experience
- (2018) Osnat Zmora et al. JOURNAL OF PEDIATRIC SURGERY
- Functional screening of FGFR4-driven tumorigenesis identifies PI3K/mTOR inhibition as a therapeutic strategy in rhabdomyosarcoma
- (2018) Timothy McKinnon et al. ONCOGENE
- MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma
- (2018) Marielle E. Yohe et al. Science Translational Medicine
- Integrative Bayesian Analysis Identifies Rhabdomyosarcoma Disease Genes
- (2018) Lin Xu et al. Cell Reports
- PAX3-FOXO1 transgenic zebrafish models identify HES3 as a mediator of rhabdomyosarcoma tumorigenesis
- (2018) Genevieve C Kendall et al. eLife
- Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group
- (2018) David S. Shulman et al. BRITISH JOURNAL OF CANCER
- Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses
- (2018) Elizabeth Stewart et al. CANCER CELL
- Loss of MST/Hippo signaling in a genetically engineered mouse model of fusion-positive rhabdomyosarcoma accelerates tumorigenesis
- (2018) Kristianne M. Oristian et al. CANCER RESEARCH
- MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification
- (2018) Narasimhan P. Agaram et al. MODERN PATHOLOGY
- tp53 deficiency causes a wide tumor spectrum and increases embryonal rhabdomyosarcoma metastasis in zebrafish
- (2018) Myron S Ignatius et al. eLife
- Different Response of Ptch Mutant and Ptch Wildtype Rhabdomyosarcoma Toward SMO and PI3K Inhibitors
- (2018) Natalie Geyer et al. Frontiers in Oncology
- The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma
- (2018) Suman Malempati et al. CANCER
- The HDAC3–SMARCA4–miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma
- (2018) Narendra Bharathy et al. Science Signaling
- PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma
- (2017) Puspa R Pandey et al. JOURNAL OF PATHOLOGY
- A Novel Notch–YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma
- (2017) Katherine K. Slemmons et al. MOLECULAR CANCER RESEARCH
- Orthotopic patient-derived xenografts of paediatric solid tumours
- (2017) Elizabeth Stewart et al. NATURE
- Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group
- (2017) Erin R. Rudzinski et al. PEDIATRIC BLOOD & CANCER
- PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
- (2017) Berkley E. Gryder et al. Cancer Discovery
- The NOTCH1/SNAIL1/MEF2C Pathway Regulates Growth and Self-Renewal in Embryonal Rhabdomyosarcoma
- (2017) Myron S. Ignatius et al. Cell Reports
- Myogenic regulatory transcription factors regulate growth in rhabdomyosarcoma
- (2017) Inês M Tenente et al. eLife
- Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma
- (2016) Elliot Kahen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcoma
- (2016) Christine M. Heske et al. Oncotarget
- Distinct methylation profiles characterize fusion-positive and fusion-negative rhabdomyosarcoma
- (2015) Wenyue Sun et al. MODERN PATHOLOGY
- Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
- (2015) Junwei Shi et al. NATURE BIOTECHNOLOGY
- Kras activation in p53-deficient myoblasts results in high-grade sarcoma formation with impaired myogenic differentiation
- (2015) Timothy McKinnon et al. Oncotarget
- Clonality and Evolutionary History of Rhabdomyosarcoma
- (2015) Li Chen et al. PLoS Genetics
- Functional genomic screening reveals asparagine dependence as a metabolic vulnerability in sarcoma
- (2015) Simone Hettmer et al. eLife
- Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database
- (2015) Philip J. Lupo et al. Cancer Medicine
- IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma
- (2015) Xiaolin Wan et al. NEOPLASIA
- The Case for Primary Salivary Rhabdomyosarcoma
- (2015) Mathew Geltzeiler et al. Frontiers in Oncology
- Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS
- (2014) Roberta Ciarapica et al. BMC CANCER
- A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance
- (2014) Alberto S. Pappo et al. CANCER
- The Hippo Transducer YAP1 Transforms Activated Satellite Cells and Is a Potent Effector of Embryonal Rhabdomyosarcoma Formation
- (2014) Annie M. Tremblay et al. CANCER CELL
- Lineage of origin in rhabdomyosarcoma informs pharmacological response
- (2014) J. Abraham et al. GENES & DEVELOPMENT
- A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
- (2014) Shinji Kohsaka et al. NATURE GENETICS
- Glycogen synthase kinase 3 inhibitors induce the canonical WNT/ -catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma
- (2014) E. Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors
- (2014) J. F. Shern et al. Cancer Discovery
- Rhabdomyosarcoma: Current Challenges and Their Implications for Developing Therapies
- (2014) S. Hettmer et al. Cold Spring Harbor Perspectives in Medicine
- Targeting Oxidative Stress in Embryonal Rhabdomyosarcoma
- (2013) Xiang Chen et al. CANCER CELL
- Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo
- (2013) J. Renshaw et al. CLINICAL CANCER RESEARCH
- A novel chemical screening strategy in zebrafish identifies common pathways in embryogenesis and rhabdomyosarcoma development
- (2013) X. Le et al. DEVELOPMENT
- Zebrafish rhabdomyosarcoma reflects the developmental stage of oncogene expression during myogenesis
- (2013) N. Y. Storer et al. DEVELOPMENT
- Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing program
- (2013) E. Anders Kolb et al. PEDIATRIC BLOOD & CANCER
- PAX-FOXO1fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report
- (2013) Stephen X. Skapek et al. PEDIATRIC BLOOD & CANCER
- Distinct and Overlapping Sarcoma Subtypes Initiated from Muscle Stem and Progenitor Cells
- (2013) Jordan M. Blum et al. Cell Reports
- Cross-Species Array Comparative Genomic Hybridization Identifies Novel Oncogenic Events in Zebrafish and Human Embryonal Rhabdomyosarcoma
- (2013) Eleanor Y. Chen et al. PLoS Genetics
- Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
- (2013) Ashley R. P. Hinson et al. Frontiers in Oncology
- A Mouse Model of Rhabdomyosarcoma Originating from the Adipocyte Lineage
- (2012) Mark E. Hatley et al. CANCER CELL
- The Not-so-Skinny on Muscle Cancer
- (2012) Ken Kikuchi et al. CANCER CELL
- PAX3/FOXO1Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk Stratification
- (2012) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies
- (2012) Suman Malempati et al. PEDIATRIC BLOOD & CANCER
- Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas
- (2012) Douglas S. Hawkins et al. PEDIATRIC BLOOD & CANCER
- Evidence for an Unanticipated Relationship between Undifferentiated Pleomorphic Sarcoma and Embryonal Rhabdomyosarcoma
- (2011) Brian P. Rubin et al. CANCER CELL
- Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21Cip1 expression and hampers tumour cell growth in vitro and in vivo
- (2011) L Raimondi et al. CELL DEATH AND DIFFERENTIATION
- Sarcomas induced in discrete subsets of prospectively isolated skeletal muscle cells
- (2011) S. Hettmer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fusion Gene–Negative Alveolar Rhabdomyosarcoma Is Clinically and Molecularly Indistinguishable From Embryonal Rhabdomyosarcoma
- (2010) Daniel Williamson et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor Effects of a Combined 5-Aza-2'Deoxycytidine and Valproic Acid Treatment on Rhabdomyosarcoma and Medulloblastoma in Ptch Mutant Mice
- (2009) I. Ecke et al. CANCER RESEARCH
- MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state
- (2009) Z. Yang et al. GENES & DEVELOPMENT
- Defining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma
- (2008) S. Naini et al. CANCER RESEARCH
- Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: Report of the HD CWS-96 trial
- (2008) Thomas Klingebiel et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More